Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Seres Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −6 vs. Q1 2024
- Shares held
- 69.1M
- −16.6M (−19.4%) vs. Q1 2024
- Total value
- $50.0M
- −$16.3M (−24.6%) vs. Q1 2024
- New holders
- 21
- 25 more added
- Sold out
- 27
- 28 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MCRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $17.9M |
| Q1 2026 | 33 | $20.5M |
| Q4 2025 | 36 | $36.4M |
| Q3 2025 | 32 | $40.9M |
| Q2 2025 | 33 | $25.4M |
| Q1 2025 | 63 | $43.1M |
| Q4 2024 | 69 | $52.5M |
| Q3 2024 | 77 | $60.1M |
| Q2 2024 | 93 | $50.0M |
| Q1 2024 | 99 | $66.3M |
| Q4 2023 | 103 | $125.4M |
| Q3 2023 | 134 | $255.6M |
| Q2 2023 | 138 | $538.1M |
| Q1 2023 | 123 | $593.9M |
| Q4 2022 | 124 | $588.2M |
| Q3 2022 | 120 | $671.6M |
| Q2 2022 | 123 | $312.7M |
| Q1 2022 | 131 | $537.2M |
| Q4 2021 | 148 | $642.8M |
| Q3 2021 | 133 | $555.1M |
| Q2 2021 | 147 | $1.93B |
| Q1 2021 | 154 | $1.85B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Seres Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −127,660−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −103,316−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −70,598−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −48,475−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −33,061−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −10,376−100.0% | Sold out |
| Summit Trail Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −9,985−100.0% | Sold out |
| California State Teachers Retirement System | 0 | $0 | 0.00% | −9,888−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −8,033−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −6,203−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −4,480−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,396−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Orion Capital Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −29,008−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −50,102−100.0% | Sold out |